156 related articles for article (PubMed ID: 15972453)
1. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes.
Matsuda A; Germing U; Jinnai I; Misumi M; Kuendgen A; Knipp S; Aivado M; Iwanaga M; Miyazaki Y; Tsushima H; Sakai M; Bessho M; Tomonaga M
Blood; 2005 Oct; 106(8):2633-40. PubMed ID: 15972453
[TBL] [Abstract][Full Text] [Related]
2. Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes.
Matsuda A; Germing U; Jinnai I; Araseki K; Kuendgen A; Strupp C; Iwanaga M; Miyazaki Y; Hata T; Bessho M; Gattermann N; Tomonaga M
Leuk Res; 2010 Aug; 34(8):974-80. PubMed ID: 20022110
[TBL] [Abstract][Full Text] [Related]
3. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
4. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
[TBL] [Abstract][Full Text] [Related]
5. A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome.
Cermák J; Michalová K; Brezinová J; Zemanová Z
Leuk Res; 2003 Mar; 27(3):221-9. PubMed ID: 12537974
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of refractory anaemia in adult myelodysplastic syndromes.
Wang XQ; Chen ZX; Chen SC; Lin GW; Ji MR; Liang JY; Liu DD; Li DG; Ma Y
Chin Med J (Engl); 2008 Sep; 121(18):1787-91. PubMed ID: 19080358
[TBL] [Abstract][Full Text] [Related]
8. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R
Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
[TBL] [Abstract][Full Text] [Related]
9. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
10. [Refractory anemia (RA) and refractory cytopenia with multilineage dysplasia (RCMD) in WHO classification: comparison between Japanese and German cases].
Matsuda A; Germing U
Rinsho Ketsueki; 2004 Apr; 45(4):268-73. PubMed ID: 15168441
[No Abstract] [Full Text] [Related]
11. Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification.
Matsuda A; Germing U; Jinnai I; Iwanaga M; Misumi M; Kuendgen A; Strupp C; Miyazaki Y; Tsushima H; Sakai M; Bessho M; Gattermann N; Aul C; Tomonaga M
Leukemia; 2007 Apr; 21(4):678-86. PubMed ID: 17268513
[TBL] [Abstract][Full Text] [Related]
12. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
13. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
[TBL] [Abstract][Full Text] [Related]
14. Hypoplastic myelodysplastic syndrome.
Nand S; Godwin JE
Cancer; 1988 Sep; 62(5):958-64. PubMed ID: 3409176
[TBL] [Abstract][Full Text] [Related]
15. [Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification].
Piguet D; Schmidt PM; Delacrétaz F; Mermillod B
Schweiz Med Wochenschr; 1987 Jan; 117(2):61-6. PubMed ID: 3468610
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndromes: a study of 101 cases according to the FAB classification.
Vallespi T; Torrabadella M; Julia A; Irriguible D; Jaen A; Acebedo G; Triginer J
Br J Haematol; 1985 Sep; 61(1):83-92. PubMed ID: 3863667
[TBL] [Abstract][Full Text] [Related]
17. [Myelodysplastic syndrome classification].
Ghariani I; Braham N; Hassine M; Kortas M
Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
19. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
Suciu S; Kuse R; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
[TBL] [Abstract][Full Text] [Related]
20. Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients.
Breccia M; Latagliata R; Cannella L; Carmosino I; Santopietro M; Loglisci G; Federico V; Alimena G
Leuk Lymphoma; 2010 May; 51(5):783-8. PubMed ID: 20302387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
